Home Akouos

Akouos

In operation
IPO
Hearing Gene Therapy Developer

Basic Information

Akouos is a biotechnology company dedicated to restoring and preserving hearing. The company utilizes gene therapy based on adeno-associated virus (AAV) vectors to restore and maintain various forms of hearing in genetically defined patient populations, ranging from single-gene mutations to ototoxic drug exposure and the aging process, enabling the healthcare industry to treat sensorineural hearing loss effectively.
Akouos, Inc.
Massachusetts,United States of America
51~100 people
January 01, 2017
info@akouos.com